The Rationale for Consuming Cognitive Enhancement Drugs in University Students and Teachers

Sattler S, Sauer C, Mehlkop G, Graeff P (2013)
PLoS ONE 8(7): e68821.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
OA
Autor*in
Sattler, SebastianUniBi ; Sauer, CarstenUniBi ; Mehlkop, Guido; Graeff, Peter
Abstract / Bemerkung
Cognitive enhancement (CE) is the pharmaceutical augmentation of mental abilities (e.g., learning or memory) without medical necessity. This topic has recently attracted widespread attention in scientific and social circles. However, knowledge regarding the mechanisms that underlie the decision to use CE medication is limited. To analyze these decisions, we used data from two online surveys of randomly sampled university teachers (N = 1,406) and students (N = 3,486). Each respondent evaluated one randomly selected vignette with regard to a hypothetical CE drug. We experimentally varied the characteristics of the drugs among vignettes and distributed them among respondents. In addition, the respondent’s internalization of social norms with respect to CE drug use was measured. Our results revealed that students were more willing to enhance cognitive performance via drugs than university teachers, although the overall willingness was low. The probability of side effects and their strength reduced the willingness to use CE drugs among students and university teachers, whereas higher likelihoods and magnitudes of CE increased this propensity. In addition, the internalized norm against CE drug use influenced decision making: Higher internalization decreased the willingness to use such medications. Students’ internalized norms more strongly affected CE abstinence compared with those of university teachers. Furthermore, internalized norms negatively interacted with the instrumental incentives for taking CE medication. This internalization limited the influence of and deliberation on instrumental incentives. This study is the first to provide empirical evidence regarding the importance of social norms and their influence on rational decision making with regard to CE. We identified previously undiscovered decision-making patterns concerning CE. Thus, this study provides insight into the motivators and inhibitors of CE drug use. These findings have implications for contending with CE behavior by highlighting the magnitude of potential side effects and by informing the debate regarding the ethics of CE use.
Erscheinungsjahr
2013
Zeitschriftentitel
PLoS ONE
Band
8
Ausgabe
7
Art.-Nr.
e68821
ISSN
1932-6203
eISSN
1932-6203
Finanzierungs-Informationen
Open-Access-Publikationskosten wurden durch die Deutsche Forschungsgemeinschaft und die Universität Bielefeld gefördert.
Page URI
https://pub.uni-bielefeld.de/record/2610651

Zitieren

Sattler S, Sauer C, Mehlkop G, Graeff P. The Rationale for Consuming Cognitive Enhancement Drugs in University Students and Teachers. PLoS ONE. 2013;8(7): e68821.
Sattler, S., Sauer, C., Mehlkop, G., & Graeff, P. (2013). The Rationale for Consuming Cognitive Enhancement Drugs in University Students and Teachers. PLoS ONE, 8(7), e68821. https://doi.org/10.1371/journal.pone.0068821
Sattler, Sebastian, Sauer, Carsten, Mehlkop, Guido, and Graeff, Peter. 2013. “The Rationale for Consuming Cognitive Enhancement Drugs in University Students and Teachers”. PLoS ONE 8 (7): e68821.
Sattler, S., Sauer, C., Mehlkop, G., and Graeff, P. (2013). The Rationale for Consuming Cognitive Enhancement Drugs in University Students and Teachers. PLoS ONE 8:e68821.
Sattler, S., et al., 2013. The Rationale for Consuming Cognitive Enhancement Drugs in University Students and Teachers. PLoS ONE, 8(7): e68821.
S. Sattler, et al., “The Rationale for Consuming Cognitive Enhancement Drugs in University Students and Teachers”, PLoS ONE, vol. 8, 2013, : e68821.
Sattler, S., Sauer, C., Mehlkop, G., Graeff, P.: The Rationale for Consuming Cognitive Enhancement Drugs in University Students and Teachers. PLoS ONE. 8, : e68821 (2013).
Sattler, Sebastian, Sauer, Carsten, Mehlkop, Guido, and Graeff, Peter. “The Rationale for Consuming Cognitive Enhancement Drugs in University Students and Teachers”. PLoS ONE 8.7 (2013): e68821.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Volltext(e)
Access Level
OA Open Access
Zuletzt Hochgeladen
2019-09-06T09:18:16Z
MD5 Prüfsumme
4131c5524d34ea80b4a5e8375d644158


Link(s) zu Volltext(en)
Access Level
Restricted Closed Access

14 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Bottom Up Ethics - Neuroenhancement in Education and Employment.
Bard I, Gaskell G, Allansdottir A, da Cunha RV, Eduard P, Hampel J, Hildt E, Hofmaier C, Kronberger N, Laursen S, Meijknecht A, Nordal S, Quintanilha A, Revuelta G, Saladié N, Sándor J, Santos JB, Seyringer S, Singh I, Somsen H, Toonders W, Torgersen H, Torre V, Varju M, Zwart H., Neuroethics 11(3), 2018
PMID: 30220937
Novelty-seeking trait predicts the effect of methylphenidate on creativity.
Gvirts HZ, Mayseless N, Segev A, Lewis DY, Feffer K, Barnea Y, Bloch Y, Shamay-Tsoory SG., J Psychopharmacol 31(5), 2017
PMID: 27624151
Perceptions of Risks and Benefits Among Nonprescription Stimulant Consumers, Diverters, and Non-Users.
Kinman BA, Armstrong KJ, Hood KB., Subst Use Misuse 52(10), 2017
PMID: 28323514
Swiss University Students' Attitudes toward Pharmacological Cognitive Enhancement.
Maier LJ, Liakoni E, Schildmann J, Schaub MP, Liechti ME., PLoS One 10(12), 2015
PMID: 26657300
Addressing the problem of ADHD medication as neuroenhancements.
Graf WD, Miller G, Nagel SK., Expert Rev Neurother 14(5), 2014
PMID: 24738763
Attitudes toward pharmacological cognitive enhancement-a review.
Schelle KJ, Faulmüller N, Caviola L, Hewstone M., Front Syst Neurosci 8(), 2014
PMID: 24860438

89 References

Daten bereitgestellt von Europe PubMed Central.

Cognitive enhancement: methods, ethics, regulatory challenges.
Bostrom N, Sandberg A., Sci Eng Ethics 15(3), 2009
PMID: 19543814
Neuroenhancement: status quo and perspectives.
Normann C, Berger M., Eur Arch Psychiatry Clin Neurosci 258 Suppl 5(), 2008
PMID: 18985306
Psychopharmacological enhancment
AUTHOR UNKNOWN, 2008
Towards responsible use of cognitive-enhancing drugs by the healthy.
Greely H, Sahakian B, Harris J, Kessler RC, Gazzaniga M, Campbell P, Farah MJ., Nature 456(7223), 2008
PMID: 19060880
The nonmedical use of prescription ADHD medications: results from a national Internet panel.
Novak SP, Kroutil LA, Williams RL, Van Brunt DL., Subst Abuse Treat Prev Policy 2(), 2007
PMID: 17974020
Neurocognitive enhancement: what can we do and what should we do?
AUTHOR UNKNOWN, 2004
The mental wealth of nations
AUTHOR UNKNOWN, 2008
Poll results: look who's doping.
Maher B., Nature 452(7188), 2008
PMID: 18401370
The perverse effects of competition on scientists' work and relationships.
Anderson MS, Ronning EA, De Vries R, Martinson BC., Sci Eng Ethics 13(4), 2007
PMID: 18030595
Cognitive enhancement, lifestyle choice or misuse of prescription drugs?
AUTHOR UNKNOWN, 2010
Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany.
Franke AG, Bonertz C, Christmann M, Huss M, Fellgiebel A, Hildt E, Lieb K., Pharmacopsychiatry 44(2), 2010
PMID: 21161883
Nonmedical prescription stimulant use among a sample of college students: relationship with psychological variables.
Weyandt LL, Janusis G, Wilson KG, Verdi G, Paquin G, Lopes J, Varejao M, Dussault C., J Atten Disord 13(3), 2009
PMID: 19767596
Illicit use of specific prescription stimulants among college students: prevalence, motives, and routes of administration.
Teter CJ, McCabe SE, LaGrange K, Cranford JA, Boyd CJ., Pharmacotherapy 26(10), 2006
PMID: 16999660

AUTHOR UNKNOWN, 0
‘Smart drugs’: do they work? Are they ethical? Will they be legal?
AUTHOR UNKNOWN, 2002
Crime and punishment: an economic approach
AUTHOR UNKNOWN, 1968

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0
Motives and perceived consequences of nonmedical ADHD medication use by college students: are students treating themselves for attention problems?
Rabiner DL, Anastopoulos AD, Costello EJ, Hoyle RH, McCabe SE, Swartzwelder HS., J Atten Disord 13(3), 2008
PMID: 18664714
Individual capacity differences predict working memory performance and prefrontal activity following dopamine receptor stimulation
AUTHOR UNKNOWN, 2005
Professor's little helper.
Sahakian B, Morein-Zamir S., Nature 450(7173), 2007
PMID: 18097378
Effects of modafinil and prazosin on cognitive and physiological functions in healthy volunteers.
Winder-Rhodes SE, Chamberlain SR, Idris MI, Robbins TW, Sahakian BJ, Muller U., J. Psychopharmacol. (Oxford) 24(11), 2009
PMID: 19493958
Donepezil improves episodic memory in young individuals vulnerable to the effects of sleep deprivation.
Chuah LY, Chong DL, Chen AK, Rekshan WR 3rd, Tan JC, Zheng H, Chee MW., Sleep 32(8), 2009
PMID: 19725251
Cognitive enhancement by drugs in health and disease.
Husain M, Mehta MA., Trends Cogn. Sci. (Regul. Ed.) 15(1), 2010
PMID: 21146447
Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory.
Clatworthy PL, Lewis SJ, Brichard L, Hong YT, Izquierdo D, Clark L, Cools R, Aigbirhio FI, Baron JC, Fryer TD, Robbins TW., J. Neurosci. 29(15), 2009
PMID: 19369539
Nonmedical use of prescription stimulants in the United States.
Kroutil LA, Van Brunt DL, Herman-Stahl MA, Heller DC, Bray RM, Penne MA., Drug Alcohol Depend 84(2), 2006
PMID: 16480836
Motives and perceived consequences of nonmedical ADHD medication use by college students
AUTHOR UNKNOWN, 2009
Targeting the cerb pathway for memory enhancers
AUTHOR UNKNOWN, 2003
Acute effects of the ampakine farampator on memory and information processing in healthy elderly volunteers.
Wezenberg E, Verkes RJ, Ruigt GS, Hulstijn W, Sabbe BG., Neuropsychopharmacology 32(6), 2006
PMID: 17119538
The promise and predicament of cosmetic neurology.
Chatterjee A., J Med Ethics 32(2), 2006
PMID: 16446417

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0
Norms and rationality. is moral behavior a form of rational action?
AUTHOR UNKNOWN, 2013
Creating and enforcing norms, with special reference to sanctions
AUTHOR UNKNOWN, 1999
Predicting dishonest actions using the theory of planned behavior
AUTHOR UNKNOWN, 1991
Conscience, Significant Others, and Rational Choice: Extending the Deterrence Model
AUTHOR UNKNOWN, 1990
Contending conceptions of the theory of rational choice
AUTHOR UNKNOWN, 1999

AUTHOR UNKNOWN, 0
The case for a multiple-utility conception
AUTHOR UNKNOWN, 1986

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0
The interplay of moral norms and instrumental incentives in crime causation
AUTHOR UNKNOWN, 2010
Modeling a rational choice theory of criminal action: subjective expected utilities, norms, and interactions
AUTHOR UNKNOWN, 2010

AUTHOR UNKNOWN, 0
Norms and rationality in electoral participation and in the rescue of jews in WWII: an application of the model of frame selection
AUTHOR UNKNOWN, 2010
Social Class and Delinquency: An Empirical Utilization of Rational Choice Theory with Cross-Sectional Data of the 1990 and 2000 German General Population Surveys (ALLBUS)
AUTHOR UNKNOWN, 2006
Explaining the decision to plagiarize: an empirical test of the interplay between rationality, norms, and opportunity
AUTHOR UNKNOWN, 2013
Characteristics of methylphenidate misuse in a university student sample
AUTHOR UNKNOWN, 2005
Illicit use of psychostimulants among college students: A preliminary study
AUTHOR UNKNOWN, 2002
Occupational stress among university teachers
AUTHOR UNKNOWN, 1994
Control, information-seeking preferences, occupational stressors and psychological well-being
AUTHOR UNKNOWN, 1992
Incentives in web surveys: methodological issues and a review
AUTHOR UNKNOWN, 2006
Factorial survey methods for studying beliefs and judgments
AUTHOR UNKNOWN, 2006
25 years of factorial surveys in sociology: a review
AUTHOR UNKNOWN, 2009
Judgments of the fairness of using performance enhancing drugs.
Sabini J, Monterosso J., Ethics Behav 15(1), 2005
PMID: 16127858
The use of vignettes in survey research
AUTHOR UNKNOWN, 1978
An examination of the effects of social desirability bias on business ethics: research results
AUTHOR UNKNOWN, 2002
Designing vignette studies in marketing
AUTHOR UNKNOWN, 2002
Validation of the Wong-Baker FACES pain rating scale in pediatric emergency department patients
AUTHOR UNKNOWN, 2010

AUTHOR UNKNOWN, 0
Reliability and validity of the Faces and Word Descriptor Scales to measure procedural pain.
Keck JF, Gerkensmeyer JE, Joyce BA, Schade JG., J Pediatr Nurs 11(6), 1996
PMID: 8991337
Social norms: internalization, persuasion, and history
AUTHOR UNKNOWN, 2000

AUTHOR UNKNOWN, 0
Low self-control, rational choice, and student test cheating
AUTHOR UNKNOWN, 1999
Shame, embarrassment, and formal sanction threats: Extending the deterrence/rational choice model to academic dishonesty
AUTHOR UNKNOWN, 1999

AUTHOR UNKNOWN, 0
Expected utility, self-control, morality, and criminal probability
AUTHOR UNKNOWN, 2010
Understanding offense specialization and versatility: a reapplication of the rational choice perspective
AUTHOR UNKNOWN, 2005
Thick rationality and the missing “brute fact”: the limits of rationalist incorporations of norms and ideas
AUTHOR UNKNOWN, 1997
A life-course view on the development of crime
AUTHOR UNKNOWN, 2005
Cognitive-enhancing substance use at German universities: frequency, reasons and gender differences.
Mache S, Eickenhorst P, Vitzthum K, Klapp BF, Groneberg DA., Wien Med Wochenschr 162(11-12), 2012
PMID: 22707077

AUTHOR UNKNOWN, 0
Enhancement of planning ability by transcranial direct current stimulation.
Dockery CA, Hueckel-Weng R, Birbaumer N, Plewnia C., J. Neurosci. 29(22), 2009
PMID: 19494149
Academic dishonesty: honor codes and other contextual influences
AUTHOR UNKNOWN, 1993
Cheating in academic institutions: A decade of research
AUTHOR UNKNOWN, 2001
Honor codes and other contextual influences on academic integrity: A replication and extension to modified honor code settings
AUTHOR UNKNOWN, 2002
Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 23874778
PubMed | Europe PMC

Suchen in

Google Scholar